Canada Life
DNLI icon

Canada Life’s Denali Therapeutics DNLI Stock Holding History

Canada Life’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$259K Hold
13,434
– – ﹤0.01% 1569
2025
Q4 		$222K Hold
13,434
– – ﹤0.01% 1605
2025
Q3 		$195K Hold
13,434
– – ﹤0.01% 1693
2025
Q2 		$188K Hold
13,434
– – ﹤0.01% 1704
2025
Q1 		$183K Hold
13,434
– – ﹤0.01% 1728
2024
Q4 		$274K Hold
13,434
– – ﹤0.01% 1719
2024
Q3 		$392K Hold
13,434
– – ﹤0.01% 1721
2024
Q2 		$312K Buy
13,434
+3,710
+38% +$71.2K ﹤0.01% 1768
2024
Q1 		$200K Hold
9,724
– – ﹤0.01% 1830
2023
Q4 		$207K Hold
9,724
– – ﹤0.01% 1841
2023
Q3 		$200K Buy
9,724
+5,400
+125% +$137K ﹤0.01% 1859
2023
Q2 		$128K Sell
4,324
-318
-7% -$8.94K ﹤0.01% 1892
2023
Q1 		$107K Hold
4,642
– – ﹤0.01% 1970
2022
Q4 		$130K Hold
4,642
– – ﹤0.01% 1938
2022
Q3 		$142K Hold
4,642
– – ﹤0.01% 1932
2022
Q2 		$137K Buy
4,642
+768
+20% +$20.1K ﹤0.01% 1874
2022
Q1 		$132K Sell
3,874
-588
-13% -$20.2K ﹤0.01% 1940
2021
Q4 		$198K Hold
4,462
– – ﹤0.01% 1873
2021
Q3 		$226K Hold
4,462
– – ﹤0.01% 1885
2021
Q2 		$350K Sell
4,462
-441
-9% -$27.3K ﹤0.01% 1815
2021
Q1 		$277K Sell
4,903
-1,141
-19% -$76.4K ﹤0.01% 1866
2020
Q4 		$504K Hold
6,044
– – ﹤0.01% 1748
2020
Q3 		$216K Hold
6,044
– – ﹤0.01% 1886
2020
Q2 		$145K Hold
6,044
– – ﹤0.01% 1969
2020
Q1 		$107K Hold
6,044
– – ﹤0.01% 1965
2019
Q4 		$104K Buy
+6,044
New +$101K ﹤0.01% 2066
2019
Q3 		– Sell
-6,503
Closed -$135K – 1435
2019
Q2 		$135K Sell
6,503
-901
-12% -$20.2K ﹤0.01% 2128
2019
Q1 		$171K Hold
7,404
– – ﹤0.01% 1915
2018
Q4 		$147K Hold
7,404
– – ﹤0.01% 2020
2018
Q3 		$161K Buy
+7,404
New +$122K ﹤0.01% 2048

Other funds holding DNLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Canada Life's DNLI Position: Q1 2026 in Review

Canada Life held its Denali Therapeutics (DNLI) position steady in Q1 2026 at 13,434 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #1569.

Canada Life first reported a position in DNLI in Q3 2018 and has held it in 30 quarters since. The position peaked at $504K in Q4 2020. 269 funds tracked by Wall St. Rank hold DNLI as of Q1 2026.

  • Canada Life held 13,434 shares of Denali Therapeutics worth $259K as of Q1 2026.
  • Canada Life left its Denali Therapeutics share count unchanged in Q1 2026.
  • Denali Therapeutics made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1569 holding.
  • Canada Life first reported a position in Denali Therapeutics in Q3 2018 and has held it in 30 quarters since.
  • Canada Life's Denali Therapeutics position peaked at $504K in Q4 2020.
  • 269 funds tracked by Wall St. Rank held Denali Therapeutics as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.